{
    "source": "Twitter for iPhone",
    "entities": {
        "mentions": [
            {
                "start": 0,
                "end": 12,
                "username": "Adam_Boyle_",
                "id": "59935808"
            },
            {
                "start": 13,
                "end": 21,
                "username": "CDG_GTR",
                "id": "925895691540447232"
            },
            {
                "start": 22,
                "end": 34,
                "username": "apoorva_nyc",
                "id": "29780473"
            },
            {
                "start": 35,
                "end": 47,
                "username": "chrislhayes",
                "id": "4207961"
            },
            {
                "start": 48,
                "end": 64,
                "username": "florian_krammer",
                "id": "704282873231237121"
            },
            {
                "start": 65,
                "end": 73,
                "username": "LabTaia",
                "id": "1239664586954911744"
            },
            {
                "start": 74,
                "end": 80,
                "username": "trvrb",
                "id": "224896427"
            },
            {
                "start": 81,
                "end": 89,
                "username": "ualbany",
                "id": "19980619"
            }
        ]
    },
    "id": "1278114524629999616",
    "text": "@Adam_Boyle_ @CDG_GTR @apoorva_nyc @chrislhayes @florian_krammer @LabTaia @trvrb @ualbany It would be a huge deal. Vectored vaccines like the Oxford vaccine use another virus to deliver the antigen payload. If you have immunity to the virus vector, they donâ€™t work well. Only works once. This is why Oxford used a chimp adenovirus vector, no existing human immunity",
    "created_at": "2020-06-30T23:53:43.000Z",
    "in_reply_to_user_id": "59935808"
}